0 205

Cited 0 times in

SOLUTION study: Effect of gemigliptin as add-on therapy to dapagliflozin plus metformin in patients with type 2 diabetes

DC Field Value Language
dc.contributor.author이병완-
dc.date.accessioned2023-06-02T01:13:01Z-
dc.date.available2023-06-02T01:13:01Z-
dc.date.issued2022-04-
dc.identifier.issn0168-8227-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194739-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherElsevier Scientific Publishers-
dc.relation.isPartOfDIABETES RESEARCH AND CLINICAL PRACTICE-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleSOLUTION study: Effect of gemigliptin as add-on therapy to dapagliflozin plus metformin in patients with type 2 diabetes-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorB.W. Lee-
dc.contributor.googleauthorK.W. Min-
dc.contributor.googleauthorE.G. Hong-
dc.contributor.googleauthorB.J. Ku-
dc.contributor.googleauthorJ.G. Kang-
dc.contributor.googleauthorS. Chon-
dc.contributor.googleauthorJ.H. Kim-
dc.contributor.googleauthorM.K. Park-
dc.contributor.googleauthorW.Y. Lee-
dc.contributor.googleauthorS.Y. Kim-
dc.contributor.googleauthorK.H. Song-
dc.contributor.googleauthorS.J. Yoo-
dc.identifier.doi10.1016/j.diabres.2022.109587-
dc.contributor.localIdA02796-
dc.relation.journalcodeJ00723-
dc.identifier.eissn1872-8227-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0168822722003990-
dc.contributor.alternativeNameLee, Byung Wan-
dc.contributor.affiliatedAuthor이병완-
dc.citation.volume186-
dc.citation.numberSuppl.1-
dc.citation.startPage109587-
dc.identifier.bibliographicCitationDIABETES RESEARCH AND CLINICAL PRACTICE, Vol.186(Suppl.1) : 109587, 2022-04-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.